Scotts Miracle-Gro (SMG) EBITDA (2009 - 2026)

Scotts Miracle-Gro has disclosed EBITDA across 18 years of filings, most recently posting $401.8 million for Q1 2026.

• EBITDA for Q1 2026 came in at $401.8 million, up 14.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $444.9 million (up 54.53% YoY), and the FY2025 annual result was $358.6 million, up 71.74% from the prior year.
• EBITDA came in at $401.8 million for Q1 2026 at Scotts Miracle-Gro, up from -$21.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $401.8 million in Q1 2026 to a low of -$562.5 million in Q3 2022.
• The 5-year median for EBITDA is -$28.6 million (2022), against an average of $19.4 million.
• Across the five-year window, EBITDA tumbled 501.88% in 2022 and surged 158.86% in 2024, its largest moves.
• Scotts Miracle-Gro's EBITDA stood at -$41.8 million in 2022, then slipped by 13.16% to -$47.3 million in 2023, then increased by 3.17% to -$45.8 million in 2024, then soared by 52.4% to -$21.8 million in 2025, then surged by 1943.12% to $401.8 million in 2026.
• The last three EBITDA figures came in at $401.8 million (Q1 2026), -$21.8 million (Q4 2025), and -$150.1 million (Q3 2025), per Business Quant data.